CI
BSX icon

Clal Insurance’s Boston Scientific BSX Stock Holding History

Clal Insurance’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22K Buy
517
+69
+15% +$3.75K ﹤0.01% 156
2026
Q1 		$28K Buy
+448
New +$35.8K ﹤0.01% 144
2021
Q2 		– Sell
-13,000
Closed -$502K – 224
2021
Q1 		$502K Hold
13,000
– – 0.01% 163
2020
Q4 		$437K Hold
13,000
– – 0.01% 122
2020
Q3 		$497K Buy
+13,000
New +$501K 0.01% 119

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Clal Insurance's BSX Position: Q2 2026 in Review

Clal Insurance increased its Boston Scientific (BSX) stake by 15% in Q2 2026, buying an estimated $3.75K and bringing the position to 517 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #156.

Clal Insurance first reported a position in BSX in Q3 2020 and has held it in 5 quarters since. The position peaked at $502K in Q1 2021. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Clal Insurance held 517 shares of Boston Scientific worth $22K as of Q2 2026.
  • Clal Insurance bought 69 Boston Scientific shares in Q2 2026, an estimated $3.75K.
  • Boston Scientific made up ﹤0.01% of Clal Insurance's portfolio in Q2 2026, its #156 holding.
  • Clal Insurance first reported a position in Boston Scientific in Q3 2020 and has held it in 5 quarters since.
  • Clal Insurance's Boston Scientific position peaked at $502K in Q1 2021.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.